75 related articles for article (PubMed ID: 18726261)
1. Construction of a fusion protein between N-terminal 153 peptide of thrombopoietin and erythropoietin.
Lu B; Liu X; Huang P
Sci China C Life Sci; 1998 Aug; 41(4):426-34. PubMed ID: 18726261
[TBL] [Abstract][Full Text] [Related]
2. Expression of the receptor MPL and proliferative effects of its ligand thrombopoietin on human leukemia cells.
Quentmeier H; Zaborski M; Graf G; Ludwig WD; Drexler HG
Leukemia; 1996 Feb; 10(2):297-310. PubMed ID: 8637239
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human c-Mpl ligand (thrombopoietin) not only acts on megakaryocyte progenitors, but also on erythroid and multipotential progenitors in vitro.
Tanimukai S; Kimura T; Sakabe H; Ohmizono Y; Kato T; Miyazaki H; Yamagishi H; Sonoda Y
Exp Hematol; 1997 Sep; 25(10):1025-33. PubMed ID: 9293899
[TBL] [Abstract][Full Text] [Related]
4. Thrombopoietin: expression of its receptor MPL and proliferative effects on leukemic cells.
Drexler HG; Quentmeier H
Leukemia; 1996 Sep; 10(9):1405-21. PubMed ID: 8751457
[TBL] [Abstract][Full Text] [Related]
5. Megakaryocytic Maturation is Regulated by Maintaining a Balance Against Cytokine Induced-cell Proliferation: Steel Factor Retards Thrombopoietin-induced Megakaryocytic Differentiation While Synergistically Stimulating Mitogenesis; Hematopoiesis.
Miyazawa K; Nishimaki J; Katagiri T; Yaguchi M; Iwase O; Gotoh A; Tauchi T; Kawanishi Y; Toyama K; Ohyashiki K; Ishibashi T; Broxmeyer HE
Hematology; 2000; 5(3):233-246. PubMed ID: 11399618
[TBL] [Abstract][Full Text] [Related]
6. Insights into the cellular mechanisms of erythropoietin-thrombopoietin synergy.
Papayannopoulou T; Brice M; Farrer D; Kaushansky K
Exp Hematol; 1996 Apr; 24(5):660-9. PubMed ID: 8605971
[TBL] [Abstract][Full Text] [Related]
7. Effects of recombinant human thrombopoietin alone and in combination with erythropoietin and early-acting cytokines on human mobilized purified CD34+ progenitor cells cultured in serum-depleted medium.
Birkmann J; Oez S; Smetak M; Kaiser G; Kappauf H; Gallmeier WM
Stem Cells; 1997; 15(1):18-32. PubMed ID: 9007219
[TBL] [Abstract][Full Text] [Related]
8. Thrombopoietin treats erythropoietin resistance by correcting EPO-induced progenitorcell depletion.
Zou H; Wong RSM; Yan X
Biochem Pharmacol; 2024 Feb; 220():116008. PubMed ID: 38154543
[TBL] [Abstract][Full Text] [Related]
9. Thrombopoietin: biology and clinical potentials.
Miyazaki H; Kato T
Int J Hematol; 1999 Dec; 70(4):216-25. PubMed ID: 10643146
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietin is a major regulator of thrombopoiesis in thrombopoietin-dependent and -independent contexts.
Hacein-Bey-Abina S; Estienne M; Bessoles S; Echchakir H; Pederzoli-Ribeil M; Chiron A; Aldaz-Carroll L; Leducq V; Zhang Y; Souyri M; Louache F; Abina AM
Exp Hematol; 2020 Aug; 88():15-27. PubMed ID: 32721504
[TBL] [Abstract][Full Text] [Related]
11. Do the preclinical effects of thrombopoietin correlate with its in vitro properties?
Kaushansky K; Broudy VC; Sitnicka E; Lofton-Day C; Grossmann A; Sprugel K
Stem Cells; 1996; 14 Suppl 1():108-11. PubMed ID: 11012209
[TBL] [Abstract][Full Text] [Related]
12. Use of human leukemia-lymphoma cell lines in hematological research: effects of thrombopoietin on human leukemia cell lines.
Drexler HG; Quentmeier H
Hum Cell; 1996 Dec; 9(4):309-16. PubMed ID: 9183663
[TBL] [Abstract][Full Text] [Related]
13. Megakaryocytopoiesis in vitro: from the stem cells' perspective.
Cardier JE; Foster DC; Lok S; Jacobsen SE; Murphy MJ
Stem Cells; 1996; 14 Suppl 1():163-72. PubMed ID: 11012217
[TBL] [Abstract][Full Text] [Related]
14. [Eukaryotic expression, purification and analysis of the fusion protein of Epo-Tpo(C)].
Wang Z; Hou Y; Yang X
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Mar; 15(1):5-8. PubMed ID: 12526292
[TBL] [Abstract][Full Text] [Related]
15. A functional erythropoietin receptor is necessary for the action of thrombopoietin on erythroid cells lacking c-mpl.
Rouleau C; Cui K; Feldman L
Exp Hematol; 2004 Feb; 32(2):140-8. PubMed ID: 15102474
[TBL] [Abstract][Full Text] [Related]
16. Thrombopoietin has a differentiative effect on late-stage human erythropoiesis.
Liu W; Wang M; Tang DC; Ding I; Rodgers GP
Br J Haematol; 1999 May; 105(2):459-69. PubMed ID: 10233422
[TBL] [Abstract][Full Text] [Related]
17. Oxygen tension alters the effects of cytokines on the megakaryocyte, erythrocyte, and granulocyte lineages.
LaIuppa JA; Papoutsakis ET; Miller WM
Exp Hematol; 1998 Aug; 26(9):835-43. PubMed ID: 9694504
[TBL] [Abstract][Full Text] [Related]
18. EVI1 is expressed in megakaryocyte cell lineage and enforced expression of EVI1 in UT-7/GM cells induces megakaryocyte differentiation.
Shimizu S; Nagasawa T; Katoh O; Komatsu N; Yokota J; Morishita K
Biochem Biophys Res Commun; 2002 Apr; 292(3):609-16. PubMed ID: 11922610
[TBL] [Abstract][Full Text] [Related]
19. [Biology of thrombopoietin and its receptors].
Robak T
Postepy Hig Med Dosw; 1996; 50(6):649-63. PubMed ID: 9064684
[TBL] [Abstract][Full Text] [Related]
20. [Physiopathologic aspects of anemia and thrombocytopenia in children with cancers: the roles of erythropoietin and thrombopoietin].
Corazza FV
Bull Mem Acad R Med Belg; 2008; 163(1-2):152-6; discussion 156-7. PubMed ID: 18819233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
